Prescribing information

 

Prescribing information

Welcome to the Entresto on-demand webinars page. Below you can access recordings from educational webinars that were hosted by experts in the field of heart failure and were organised by Novartis.

You will be required to register to watch the videos.

chronic-hfref-patients-video-screenshot

What can I do to keep my chronic HFrEF patients out of hospital?

Watch Jacqui Hyland, Dr Matt Fay and Dr Simon Williams discuss chronic heart failure management in primary care. Listen to the experts exchange views on how the future of heart failure management is evolving, and where they position Entresto in the chronic heart failure treatment pathway.
 

Watch

early-initiation-entresto-screenshot

Early initiation of Entresto® (sacubitril/valsartan): alter the cycle of readmission in patients with heart failure

Watch Dr Aaron Wong present key findings from two studies in treatment of patients with chronic heart failure, and share his local data on the early initiation of Entresto.
 

Watch

 

Screengrab of video detailing: Five years of experience with Entresto (sacubitril/valsartan): looking back and moving forward – virtual symposium

Five years of experience with Entresto (sacubitril/valsartan): looking back and moving forward – virtual symposium

A recording from the Novartis symposium at the British Society for Heart Failure’s 23rd annual autumn meeting, which took place virtually.

Prominent cardiologists Dr Patricia Campbell and Professor Mark Petrie exchange their experiences on using Entresto in the field of chronic heart failure.
 

Watch

Screenshot of video detailing: Making every contact count: the role of primary care in the management of patients with chronic heart failure

Making every contact count: the role of primary care in the management of patients with chronic heart failure

The webinar event was held on the 9th September 2020 and was organised by Novartis.

Hear Dr Matt Fay discuss the Bradford CCG heart failure pathway, Professor Roy Gardner talk about licensed treatments for chronic heart failure and Dr Majid Akram share how to get the most out of virtual consultations.
 

Watch videos

 

Indication: Entresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.1

CCG, clinical commissioning group; HFrEF, heart failure with reduced ejection fraction.

Reference

  1. Entresto Summary of Product Characteristics, 2020.
UK | December 2020 | 101187
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]